Dr. Ladiges’s current research interest is in the discovery and testing of anti-aging therapeutics to treat and prevent aging and disease conditions associated with aging. This concept has the potential to help establish a new approach in treating elderly patients suffering from chronic and often multi-morbid disease conditions by treating aging as a distinct entity with single drugs or drug combinations that target molecular pathways associated with aging. Dr. Ladiges is Director of the Geropathology Research Network. He has overseen the development of the Geropathology Grading Platform, which is a standard set of guidelines designed to determine the level of severity of lesions in organs from aged mice, and other mammalian species. Dr. Ladiges is Editor-in-Chief of the journal Aging Pathobiology and Therapeutics. He is a member of the National Institute on Aging Review Group, and External Advisory Board, Mutant Mouse Resource and Research Centers. He is a graduate of the College of Veterinary Medicine at Washington State University.